• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Beeline Medicines

Beeline Medicines

  • Clinical Trials
  • Presentations & Publications
  • Focus
  • Science
  • About
  • News
  • Careers
  • Connect

Presentations & Publications

Explore scientific presentations and publications about our investigational programs.

Filter by Type:

Filter by Year:

Search

March 2022 Presentation

ACS National Meeting

Optimization of indole-based antagonists of toll-like receptors 7 and 8 (TLR7/8)

View Presentation View Abstract

March 2022 Poster

ASCPT

BMS-986256, An Oral Novel Toll-like Receptor 7 and 8 (TLR7/8) Inhibitor, Is Not A Sensitive Substrate of Cytochrome P450 3A4: Clinical Evaluation with Itraconazole

View Poster View Abstract

March 2022 Poster

ACS National Meeting

Structure-based design of 2-(pyridin-2(1H)-one)indoles as antagonists of the toll-like receptors TLR7 and TLR8 for the treatment of autoimmune diseases

View Poster View Abstract

November 2021 Poster

ACR Convergence

First-in-Human Safety, Pharmacokinetic and Pharmacodynamic Study of Escalating Single- and Multiple-Doses of BMS-986256, a Novel, Potent, Oral Inhibitor of TLR7 and TLR8

View Poster View Abstract

November 2021 Presentation

ACR Convergence

Inhibition of Toll-Like Receptor 7 (TLR7) with the Potent and Selective Inhibitor of Human TLR7 and TLR8 BMS-986256 Provides Robust Efficacy in Murine Lupus Models, Reversing Established Disease

View Presentation View Abstract

November 2021 Poster

ACR Convergence

BMS-986256, an Oral Novel Toll-like Receptor 7 and 8 (TLR7/8) Inhibitor, Does Not Affect the Pharmacokinetics of Mycophenolate Mofetil in Healthy Subjects

View Poster View Abstract

  • Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page
On this page you may select links to key publications from peer-reviewed journals as well as to materials presented at scientific conferences relating to either research studies involving Beeline’s investigational product candidates or to the science guiding our research and development efforts. The safety and efficacy of any investigational product discussed in these materials has yet to be determined. Note that certain of these materials were authored by unaffiliated third parties and do not represent Beeline’s views. The content of each work is the property of the respective copyright holder and may not be further distributed without their express permission. The information in these materials may not be current or comprehensive, and Beeline undertakes no obligation to correct or update such information.

Footer

©Beeline Medicines 2026

  • Focus
  • Science
  • About
  • News
  • Careers
  • Connect
  • Privacy Notice
  • Health Privacy Policy
  • Cookie Policy
  • Terms of Use
  • LinkedIn
logo
  • Focus
  • Science
  • About
  • News
  • Careers
  • Connect
  • Clinical Trials
  • Presentations & Publications

You are now leaving Beeline Medicines' website

You are about to leave Beeline Medicines' website. Beeline Medicines assumes no responsibility for the information, statements or other content you may encounter on third-party websites.

Continue